Patent details
EP4142734 Title: LOCAL ADMINISTRATION OF NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS FOR THE INHIBITION OF CORONAVIRUS INFECTIONS
Basic Information
- Publication number:
- EP4142734
- PCT Application Number:
- US2021029375
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP217276302
- PCT Publication Number:
- WO2021222230
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- LOCAL ADMINISTRATION OF NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS FOR THE INHIBITION OF CORONAVIRUS INFECTIONS
- French Title of Invention:
- ADMINISTRATION LOCALE D'AGONISTES DU RÉCEPTEUR NICOTINIQUE DE L'ACÉTYLCHOLINE POUR L'INHIBITION D'INFECTIONS À CORONAVIRUS
- German Title of Invention:
- LOKALE VERABREICHUNG VON NIKOTINISCHEN ACETYLCHOLINREZEPTORAGONISTEN ZUR HEMMUNG VON CORONAVIRUSINFEKTIONEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 03/09/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 10/09/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 20/08/2025
- Unitary Effect Registration Date:
- 10/09/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 27/04/2021
- Grant date:
- 20/08/2025
- EP Publication Date:
- 08/03/2023
- PCT Publication Date:
- 04/11/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/08/2025
- EP B1 Publication Date:
- 20/08/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 27/04/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/08/2025
- Name:
- Oyster Point Pharma, Inc.
- Address:
- 202 Carnegie Center, Suite 109, Princeton, New Jersey 08540, United States (US)
Inventor
1
- Name:
- CARLSON, Eric C
- Address:
- United States (US)
2
- Name:
- NAU, Jeffrey Alan
- Address:
- United States (US)
Priority
- Priority Number:
- 202063016886 P
- Priority Date:
- 28/04/2020
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/55; A61K 9/00; A61K 31/506; A61K 33/34; A61P 31/14;
Publication
European Patent Bulletin
1
- Issue number:
- 202534
- Publication date:
- 20/08/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202541
- Publication date:
- 08/10/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202542
- Publication date:
- 15/10/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|